Anand Sivaraman, Founder and CEO of Remidio: “To favorably impact the economics of delivery of healthcare solutions at scale, I believe that product innovations need to be combined with delivery innovations and business model innovations that challenge existing paradigms. I also believe that looking at constraints posed by a developing nation context – be it with respect to infrastructure, skilled human resources or extreme affordability in product costing – as an opportunity to innovate will result in scalable solutions that will be extremely relevant even in the first world context.” Remidio Remidio is focused on impacting vision impairment by decentralizing eye testing and enabling early detection of eye diseases by making screening available at home. It takes a holistic approach that marries innovative, simple-to-use ophthalmic devices with state-of-the-art artificial intelligence, embodying the mantras ‘Make it simple’ and ‘Be the world’s first.’ Remidio works with global partners to provide point-of-care screening solutions for the principal causes of blindness. Uniquely integrating high-quality hardware with offline on-the-edge AI solutions, its products can be easily operated by individuals without medical training while maintaining clinical-grade outcomes.
The case can be used by instructors to illustrate questions related to AI, business model innovation, globalization, and entrepreneurship in emerging markets.
- Healthcare
- AI
- emerging markets
- entrepreneurship
- global strategy
- SDG1 No Poverty
- SDG3 Good Health & Well-Being
- SDG10 Reduced Inequality
- SDG17 Partnerships for the Goals
- Q12025